Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

GE17-5478-01

Capto L

Cytiva 17-5478-01, pack of 25 mL

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
41106500
NACRES:
NA.56

ligand

recombinant protein L (E. coli), mammalian free

Confezionamento

pack of 25 mL

Produttore/marchio commerciale

Cytiva 17-5478-01

Condizioni di stoccaggio

(20% Ehtanol)

Matrice

rigid, highly cross-linked agarose

Dimens. media delle particelle

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

working range

2-10(pH interval where the medium can be operated without significant change in function.)

Compatibilità

suitable for bioprocess medium

Temperatura di conservazione

2-8°C

Descrizione generale

Capto L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.

Affinity resin for antibody fragment purification

Capto L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains. The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.

Using this protein L resin

Capto L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.

Applicazioni

Purification of antibody fragments using affinity chromatography

Caratteristiche e vantaggi

  • Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
  • High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
  • Enables a platform approach to antibody fragment purification.
  • Excellent productivity, process economy, and process design flexibility due to rigid matrix.
  • Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
  • Fulfills industrial demands for security of supply, robust performance, and regulatory support.

Stoccaggio e stabilità

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Risultati analitici

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Note legali

Capto is a trademark of Cytiva

Pittogrammi

Flame

Avvertenze

Warning

Indicazioni di pericolo

Codice della classe di stoccaggio

3 - Flammable liquids


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 3

1 of 3

Capto™ adhere Cytiva 17-5444-10, pack of 25 mL

GE17-5444-10

Capto adhere

Capto™ Q Cytiva 17-5316-10, pack of 25 mL

GE17-5316-10

Capto Q

Protocolli

This page shows how to purify antibody fragments by affinity chromatography using Capto L products from GE Healthcare.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.